New-mexico | Prescription Drug Monitoring Programs: Critical Elements of Effective State Legislation

Does the state have legislation authorizing a PDMP?

Does this state require dispensers to report data to the PDMP on all controlled substances in Schedules II through V?

Must the prescriber review the patient's prescription history prior to prescribing either a federal II, III, and IV controlled substance or benzodiazepines and opioids?

Are prescribers who are licensed to prescribe controlled substances and registered with the DEA required to register with the PDMP?

Are state-licensed pharmacists required to register with the PDMP?

Does the PDMP allow delegates to access data?

What parties have access to PDMP data?

What programs or professionals are permitted to receive specific PDMP data upon request?

Does the law allow patients to access their own PDMP data?

Are parents of patients who are minor children allowed to access their child's own PDMP data?

Does the law allow in-state law enforcement to access PDMP data?

Does the law allow out-of-state law enforcement to access PDMP data?

Does the law require the PDMP to share data with other state PDMPs?

Does the law permit or require the PDMP to release de-identified data for research or education?

What must the PDMP and the state health department collaborate on to improve the community?

What must the PDMP and the state agency on substance abuse services collaborate on to improve the community?

Must the PDMP and law enforcement work together to identify and track risky prescribing intersecting with high risk prescription drug behavior and data on arrests, seizures, or use of other drugs (e.g. heroin)?

Must the PDMP assist prescribers in referring patients to pain and substance use disorder treatment?

Must the PDMP provide guidelines to prescribers or dispensers on how to intervene with persons with possible substance abuse disorders?

Must the PDMP refer prescribers or dispensers whom the data indicate may be impaired to the appropriate professional licensing or certification agency for investigation or further referral to an impaired professional's association?

Does the law exempt the PDMP from open record or FOIA laws?

Does the PDMP law include penalties for knowingly disclosing, using, or obtaining unauthorized PDMP information?

Is the PDMP administering agency required to maintain procedures to protect the privacy and confidentiality of patients and ensure their data is not disclosed or used except as authorized by law?

Are auditable records required to be kept of every release of identified PDMP data?

How long does the law allow PDMP data to be stored by the administrative agency?

Does the law require evaluation of the PDMP?

Must the PDMP produce reports to track trends in controlled substance use, PDMP performance or PDMP impact?

Is the PDMP required or permitted to identify suspicious or statistically outlying prescribing, dispensing or purchasing activity?